Humanizing Drug Discovery | David Altshuler

Thursday, March 05, 2020

Humanizing Drug Discovery | David Altshuler || Radcliffe Institute

In the past 30 years, genetics and genomics have exponentially expanded our understanding of human biology and disease. That understanding has the greatest potential benefit for society when it catalyzes the discovery and development of new medicines with the potential to transform the lives of patients in need.

David Altshuler discusses two recent examples of the combination of genetic insights into human biology and the invention of new treatment modalities. Specifically, he focuses on protein-folding correction for cystic fibrosis and investigative CRISPR-based gene-editing approaches for sickle cell disease and beta thalassemia.